Home  »  Finance   »  Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) Sto...

Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) Stock: What You Missed This Week

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) price closed higher on Monday, February 12, jumping 10.69% above its previous close.

A look at the daily price movement shows that the last close reads $1.31. The company’s 5Y monthly beta was ticking 1.89. Taking into account the 52-week price action we note that the stock hit a 52-week high of $218.46 and 52-week low of $1.21. The stock subtracted -30.62% on its value in the past month.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

On average, analysts have forecast the company’s revenue for the quarter will hit $240k, with the likely lows of $240k and highs of $240k. Staying with the analyst view, there is a consensus estimate of $1.22 million for the company’s annual revenue in 2019.

Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give BDRX a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.

The overview shows that BDRX’s price is at present -14.78% off the SMA20 and -39.21% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 36.34, with weekly volatility standing at 28.71%. The indicator jumps to 16.18% when calculated based on the past 30 days. Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s beta value is holding at 1.47, while the average true range (ATR) indicator is currently reading 0.28.

An analysis of the Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) stock in terms of its daily trading volume indicates that the 3-month average is 2.14. However, this figure increases on the past 10-day timeline to an average of 1.24 million.

The percentage share held by institutions stands at 5.89%. The stats also highlight that short interest as of Jan 31, 2024, stood at 45350.0 shares, which puts the short ratio at the time at 0.94. From this we can glean that short interest is 1.79% of company’s current outstanding shares. Notably, we see that shares short in January fall slightly given the previous month’s figure stood at 85070.0. But the -45.90% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Leave a Reply